High Quality Specific ChIP-validated Antibodies

摘要

Chromatrap, a business unit of Porvair Sciences Ltd, has announced the launch of its own range of Chromatin Immunoprecipitation (ChlP)-validated antibodies. Building on the company's success in the solid-state ChIP market, which underpins modern epigenetic research, the addition of ChlP-validated antibodies further enhances the high performance application solutions that Chromatrap can provide researchers.